Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 21, 2018 - Issue 9
284
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Agaricus blazei extract abrogates rotenone-induced dopamine depletion and motor deficits by its anti-oxidative and anti-inflammatory properties in Parkinsonic mice

, , , , , , , & ORCID Icon show all

References

  • Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA 2014;311:1670–83. doi: 10.1001/jama.2014.3654
  • Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, Fornai F. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res 2010;355:195–206. doi: 10.1016/j.brainres.2010.07.076
  • Maslin P. Rotenone. Pesticide News 2001;54:20–1.
  • Hisata JS. Lake and stream rehabilitation: rotenone use and health risks. Final supplemental environmental impact statement. Olympia, WA: Department of Fish and Wildlife; 2002.
  • Horgan DJ, Ohno H, Singer TP. Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XV. interactions of piericidin with the mitochondrial respiratory chain. J Biol Chem 1968;243:5967–76.
  • Schuler F, Casida JE. Functional coupling of PSST and ND1 subunits in NADH: ubiquinone oxidoreductase established by photo affinity labeling. Biochim Biophys Acta 2001;1506:79–87. doi: 10.1016/S0005-2728(01)00183-9
  • Dhanalakshmi C, Janakiraman U, Manivasagam T, Thenmozhi AJ, Essa MM, Kalandar A, et al. Vanillin attenuated behavioural impairments, neurochemical deficts, oxidative stress and apoptosis against rotenone induced rat model of Parkinson’s disease. Neurochem Res 2016;41:1899–910. doi: 10.1007/s11064-016-1901-5
  • Corona JC, Gimenez-Cassina A, Lim F, Diaz-Nido J. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson’s disease. J Neurosci Res. 2010;88:1943–50.
  • Gao HM, Liu B, Hong JS. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 2003;23:6181–7.
  • Hirsch EC, Hunot S. Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 2009;8:382–97. doi: 10.1016/S1474-4422(09)70062-6
  • Wang H, Fu Z, Han C. The medicinal values of culinary-medicinal royal sun mushroom (Agaricus blazei Murrill). Evid Based Complement Alternat Med 2013;2013:842619.
  • Val CH, Brant F, Miranda AS, Rodrigues FG, Oliveira BC, Santos EA, et al. Effect of mushroom agaricus blazei on immune response and development of experimental cerebral malaria. Malar J 2015;4:311. doi: 10.1186/s12936-015-0832-y
  • Soares AA, de Oliveira AL, de Sá-Nakanishi AB, Comar JF, Rampazzo AP, Vicentini FA, et al. Effects of an Agaricus blazei aqueous extract pretreatment on paracetamol-induced brain and liver injury in rats. Biomed Res Int 2013;2013:469180.
  • deSá-Nakanishi AB, Soares AA, Natali MRM, Comar JF, Peralta RM, Bracht A. Effects of the continuous administration of an Agaricus blazei extract to rats on oxidative parameters of the brain and liver during aging. Molecules 2014;19:18590–603. doi: 10.3390/molecules191118590
  • Johnson E, Forland DT, Saetre L, Bernardshaw SV, Lyberg T, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo. Scand J Immunol 2009;69:242–50. doi: 10.1111/j.1365-3083.2008.02218.x
  • Richter F, Hamann M, Richter A. Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice. J Neurosci Res 2007;85:681–91. doi: 10.1002/jnr.21159
  • Santosa JR, Cunhaa JA, Dierschnabela AL, Campeloa CLC, Leaoa AHF, Silva AH, et al. Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine. Behav Brain Res 2013;253:68–77. doi: 10.1016/j.bbr.2013.06.031
  • Abdelkader NF, Arafa NM, Attia AS, Ain-Shoka AA, Abdallah DM. Pyrrolidinedithiocarbamate ameliorates rotenone-induced Parkinson’s disease in rats. Bulletin Facult Pharmacy Cairo Univ 2016;55:107–13. doi: 10.1016/j.bfopcu.2016.11.003
  • Rajasankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: A potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson’s disease. Neurosci Lett 2009;454:11–5. doi: 10.1016/j.neulet.2009.02.044
  • Rozas G, Guerra MJ, Labandeira-García JL. An automated rotarod method for quantitative drug–free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res. Brain Res Protoc 1997;2:75–84. doi: 10.1016/S1385-299X(97)00034-2
  • Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism. J Neurosci Methods 2003;123:189–200. doi: 10.1016/S0165-0270(02)00360-6
  • Muralikrishnan D, Mohanakumar KP. Neuroprotection by bromocriptine against 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine induced neurotoxicity in mice. FASEB J 1998;12:905–12. doi: 10.1096/fasebj.12.10.905
  • Utley HC, Bernheim F, Hochslein P. Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 1967;118:29–32. doi: 10.1016/0003-9861(67)90273-1
  • Tamilselvam K, Nataraj J, Janakiraman U, Manivasagam T, Essa MM. Antioxidant and anti-inflammatory potential of hesperidin against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced experimental Parkinson's disease in mice. Int J Nutr Pharmacol Neurol Dis 2013;3:294–302. doi: 10.4103/2231-0738.114875
  • Jollow DJ, Mitchell JR, Zampagloine N, Gillette JR. Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzeneoxide as the hepatotoxic intermediate. Pharmacol 1974;11:151–69. doi: 10.1159/000136485
  • Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller D. Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: Possible implication in analgesic neuropathy. Biochem Pharmacol 1984;33:1801–7. doi: 10.1016/0006-2952(84)90353-8
  • Claiborne A. Catalase activity. In: RA Greenwald, (eds.) CRC handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press; 1985. p. 283–4.
  • Oberley LW, Spitz DR. Assay of superoxide dismutase activity in tumor tissue. Methods Enzymol 1984;l05:457–64. doi: 10.1016/S0076-6879(84)05064-3
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.
  • Anandhan A, Tamilselvam K, Radhiga T, Rao S, Essa MM, Manivasagam T. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson’s disease. Brain Res 2012;1433:104–13. doi: 10.1016/j.brainres.2011.11.021
  • Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P, et al. Subacute systemic 3-nitropro-pionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience 2002;114:1005–17. doi: 10.1016/S0306-4522(02)00205-1
  • Sedelis M, Schwarting RK, Huston JP. Behavioral phenotyping of the MPTP mouse model of Parkinson’s disease. Behav Brain Res 2001;125:109–25. doi: 10.1016/S0166-4328(01)00309-6
  • Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, et al. Generation of a alpha-synuclein-based rat model of Parkinson’s disease. Neurobiol Dis 2008;30:8–18. doi: 10.1016/j.nbd.2007.11.002
  • Thiffault C, Langston JW, Di Monte DA. Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res 2000;885(2):283–8. doi: 10.1016/S0006-8993(00)02960-7
  • Gao ZG, Cui WY, Zhang HT, Liu CG. Effects of nicotine on 1-methyl, 4-phenyl 1,2,3,6 tetrahydropyridine induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice. Pharmacol Res 1998;38:101–6. doi: 10.1006/phrs.1998.0337
  • Zhang C, Gao X, Sun Y, Sun X, Wu Y, Liu Y, et al. Anxiolytic effects of royal sun medicinal mushroom, Agaricus brasiliensis (Higher Basidiomycetes) on Ischemia-induced anxiety in rats. Int J Med Mushrooms 2015;17:1–10. doi: 10.1615/IntJMedMushrooms.v17.i1.10
  • Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999;222:236–45. doi: 10.1046/j.1525-1373.1999.d01-140.x
  • Seaton TA, Cooper JM, Schapira AH. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 1997;777:110–8. doi: 10.1016/S0006-8993(97)01034-2
  • Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 1989;52:381–9. doi: 10.1111/j.1471-4159.1989.tb09133.x
  • Saravanan KS, Sindhu KM, Mohanakumar KP. Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J Pineal Res 2007;42:247–53. doi: 10.1111/j.1600-079X.2006.00412.x
  • Carneiro AAJ, Ferreira ICFR, Dueñas M, Barros L, da Silva R, Gomes E, et al. Chemical composition and antioxidant activity of dried powder formulations of Agaricus blazei and Lentinusedodes. Food Chem 2013;138:2168–73. doi: 10.1016/j.foodchem.2012.12.036
  • Hakime-silva RA, Vellosa JC, Khalil NM, Khalil OA, Brunetti IL, Oliveira OM. Chemical, enzymatic and cellular antioxidant activity studies of Agaricus blazei Murrill. An Acad Bras Cienc 2013;85:1073–81. doi: 10.1590/S0001-37652013005000044
  • Greenwood B. Review: intermittent preventive treatment – A new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health 2006;11:983–91. doi: 10.1111/j.1365-3156.2006.01657.x
  • Abrahamsson PA. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49–59. doi: 10.1016/j.eururo.2009.07.049
  • Hissin PJ, Hilf RA. Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214–26. doi: 10.1016/0003-2697(76)90326-2
  • Sedlak J, Lindsay RH. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 1968;25:192–205. doi: 10.1016/0003-2697(68)90092-4
  • de Sá-Nakanishi AB, Soares AA, de Oliveira AL, Comar JF, Peralta RM, Bracht A. Effects of treating old rats with an aqueous Agaricus blazei extract on oxidative and functional parameters of the brain tissue and brain mitochondria. Oxid Med Cell Longev 2014;2014:563179. doi: 10.1155/2014/563179
  • Subash S, Essa MM, Al-Asmi A, Al-Adawi S, Vaishnav R, Braidy N, et al. Pomegranate from Oman alleviates the brain oxidative damage in transgenic mouse model of Alzheimer’s disease. J Trad Complemen Med 2014;4:232–8. doi: 10.4103/2225-4110.139107
  • Muthaiyah B, Essa MM, Lee M, Chauhan V, Kaur K, Chauhan A. Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of Alzheimer's disease. J Alz Dis 2014;42:1397–405.
  • Rausch WD, Hirata Y, Nagatsu T, Riederer P, Jellinger K. Tyrosine hydroxylase activity in caudate nucleus from Parkinson’s disease: effects of iron and phophorylating agents. J Neurochem. 1988;50:202–8. doi: 10.1111/j.1471-4159.1988.tb13250.x
  • Borges CR, Geddes T, Watson JT, Kuhn DM. Dopamine biosynthesis is regulated by S-glutathionylation potential mechanism of tyrosine hydroxylase inhibition during oxidative stress. J Biol Chem. 2002;277:48295–302. doi: 10.1074/jbc.M209042200
  • Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I. S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med. 2004;8:201–12. doi: 10.1111/j.1582-4934.2004.tb00275.x
  • Oyagi A, Oida Y, Hara H, Izuta H, Shimazawa M, Matsunaga N, et al. Protective effect of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo madels of Parkinson’s disease. Brain Res. 2008;1214:169–76. doi: 10.1016/j.brainres.2008.02.073
  • McGeer PL, McGeer EG. Glial reactions in Parkinson’s disease. Mov Disord 2008;23:474–83. doi: 10.1002/mds.21751
  • Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl 2006;70:373–81. doi: 10.1007/978-3-211-45295-0_57
  • Khan MM, Kempuraj D, Thangavel R, Zaheer A. Protection of MPTP-induced neuroinflammation and neurodegeneration by pycnogenol. Neurochem. Int 2006;62:379–88. doi: 10.1016/j.neuint.2013.01.029
  • Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson’s disease. Neuroscience. 1993;52:1–6. doi: 10.1016/0306-4522(93)90175-F
  • Niranjan R. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes. Mol Neurobiol 2014;49:28–38. doi: 10.1007/s12035-013-8483-x
  • Litteljohn D, Mangano E, Clarke M, Bobyn J, Moloney K, Hayley S. Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease. Parkinsons Dis 2010;2011:713517.
  • Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P. Bcl-2 protein is increased in the brain from parkinsonian patients. Neurosci Lett 1996;215:137–9. doi: 10.1016/0304-3940(96)12961-X
  • Forland DT, Johnson E, Saetre L, Lyberg T, Lygren I, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn’s disease. Scand J Immunol 2011;73:66–75. doi: 10.1111/j.1365-3083.2010.02477.x
  • Selvakumar GP, Janakiraman U, Essa MM, Justin Thenmozhi A, Manivasagam T. Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease. Brain Res 2014;1585:23–36. doi: 10.1016/j.brainres.2014.03.010
  • Ohja S, Javed H, Azimullah S, AbulKhair SB, Haque MH. Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson’s disease. Neurotox Res 2016;29:275–87. doi: 10.1007/s12640-015-9579-z
  • Wang P, Li XT, Sun L, Shen L. Anti-Inflammatory activity of water soluble polysaccharide of Agaricus blazei Murill on ovariectomized osteopenic rats. Evid Based Complement Alternat Med 2013;2013:164817.
  • Yu L, Yang S, Sun L, Jiang YF, Zhu LY. Effects of selenium-enriched Agaricus blazei Murill on liver metabolic dysfunction in mice, a comparison with selenium-deficient Agaricus blazei Murill and sodium selenite. Biol Trace Elem Res 2014;160:79–84. doi: 10.1007/s12011-014-0022-8
  • Numakawa T, Matsumoto T, Numakawa Y, Richards M, Yamawaki S. Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J Toxicol 2011;2011:405194. doi: 10.1155/2011/405194
  • Venkatesh Gobi V, Rajasankar S, Ramkumar M, Dhanalakshmi C, Manivasagam T, Justin Thenmozhi A, et al. Agaricus blazei extract attenuates rotenone-induced apoptosis through its mitochondrial protective and antioxidant properties in SH-SY5Y neuroblastoma cells. Nutr Neurosci 2016:1–11 (in press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.